ClinConnect ClinConnect Logo
Search / Trial NCT07021235

Proof of Concept of the Aiinane Preoperative Risk Assessment Tool.

Launched by ANCOR SERRANO · Jun 6, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Pre Anesthetic Assessment Perioperative Risk Artificial Intelligence Robotic Process Automation

ClinConnect Summary

This clinical trial is testing a new tool called the Aiinane Preoperative Risk Assessment Tool, designed to help doctors evaluate the risks of patients who are scheduled for breast cancer surgery. The goal is to improve the way patients are assessed before surgery, reducing the chances of last-minute cancellations and ensuring that high-risk patients receive the care they need. The tool uses advanced technology to analyze various health factors, helping to identify patients who are low-risk and those who may need extra attention.

To participate in the trial, individuals must be adults (18 years or older) who are scheduled for surgery to treat breast cancer and are willing to undergo a pre-anesthetic evaluation. It’s important that participants can understand the study and provide written consent. Those who are unable to participate due to other health issues, are scheduled for surgery within a week of enrollment, or are pregnant will not be included. Throughout the study, participants can expect a thorough evaluation to help ensure their safety and prepare them for surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult patients (age ≥18 years) of both sexes. Although breast neoplasia is a pathology with high prevalence in the female biological gender, we do not rule out recruiting patients of male biological gender.
  • Who have been indicated for breast surgery to resolve breast cancer pathology.
  • Who will undergo a pre-anesthetic evaluation during the inclusion period..
  • Subjects must understand the nature of the study procedures and provide written informed consent prior to any study-related procedures.
  • Exclusion Criteria:
  • Surgery scheduled for \<7 days from enrollment
  • Inability to participate in the study, in the opinion of the investigator, due to, for example, severe brain damage, language barrier, dementia, or other clinically significant or unstable conditions.
  • Subject's participation in any other clinical study.
  • Subjects dependent (as employee or relative) of the promoter or researcher.
  • Subjects placed in an institution by virtue of an order issued by either judicial or administrative authorities.
  • Limited legal capacity or incapacity.
  • Pregnancy.

About Ancor Serrano

Ancor Serrano is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on precision medicine, Ancor Serrano collaborates with healthcare professionals, regulatory bodies, and research institutions to conduct rigorous clinical studies that adhere to the highest ethical and scientific standards. The organization prides itself on fostering a patient-centric approach, ensuring that the needs and safety of participants are prioritized throughout the research process. Through its commitment to transparency and excellence, Ancor Serrano aims to contribute significantly to the development of groundbreaking treatments across various therapeutic areas.

Locations

Hospitalet De Llobregat, Barcelona, Spain

Patients applied

0 patients applied

Trial Officials

Ancor Serrano Afonso, MD, PhD

Principal Investigator

Bellvitge University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported